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IAGNOSIS OF pheochromocytoma still poses considerable problems, as almost half of patients initially have no or only paroxysmal hypertension or may even be asymptomatic. 1 Even the classic symptom triad of bilateral diffuse headache, sweating, and palpitations provides diagnostic accuracy of only 6%. 2 Autopsy studies show that the disease is not recognized in 20% to 75% of patients during life but represents the cause of death in half of them. 3, 4 Proper diagnosis of pheochromocytoma by highly sensitive biochemical tests therefore remains of paramount importance.
Simple biochemical screening, largely independent of external influences such as posture or stress, in general should improve the diagnostic sensitivity. Improved accuracy in the diagnosis of pheochromocytoma has been suggested 5 with the use of determination of plasma metanephrines (metanephrine and normetanephrine), the O-methylated extraneuronal metabolites of catecholamines, by highperformance liquid chromatography with electrochemical detection. 6 Recently, an extended report by Eisenhofer et al 7 favored plasma metanephrines in particular for oligosymptomatic, and even asymptomatic subjects at high risk for pheochromocytoma, such as patients with von Hippel-Lindau disease or family members of patients with multiple endocrine neoplasia type 2 (MEN 2). 7 However, the superiority of plasma metanephrines has not yet been supported by others.
The aims of this study were (1) to compare the diagnostic efficacy of plasma catecholamines and metanephrines, (2) to investigate the suggested independence 8 of plasma metanephrines of large increases in plasma catecholamine concentrations in patients with pheochromocytoma compared with those with histologically proved other adrenal tumors, and (3) to observe the intraoperative time course of metanephrine and catecholamine levels in patients with pheochromocytoma.
RESULTS

DIAGNOSTIC EFFICACY
All patients with pheochromcytoma were separated from all patients with other adrenal tumors by determination of plasma normetanephrine level (Figure 1) . Plasma metanephrine testing was falsely negative in 5 of the 17 patients with pheochromocytoma. However, these 5 patients (4 with adrenal tumors and 1 with an extraadrenal sporadic tumor) had elevated normetanephrine concentrations. Thus, measurement of plasma normeta-
PATIENTS AND METHODS
PATIENTS
We studied 17 patients with pheochromocytoma and 14 patients with histologically verified other adrenal tumors ( Table 1) . In 3 patients the diagnosis of MEN 2A was proved by identification of germline mutations of the RET protooncogene. Fourteen patients with pheochromocytoma (all but 1 with sporadic disease) had sustained hypertension (systolic blood pressure of Ͼ140 mm Hg or diastolic blood pressure of Ͼ90 mm Hg). Two other patients (1 with sporadic pheochromocytoma and 1 with MEN 2A) had documented periods of intermittent hypertension. All patients with hypertension and an additional patient with normal blood pressure (with the familial disease) also reported symptoms of pheochromocytoma (eg, headache, palpitations, or excessive sweating). Patients with histologically confirmed other adrenal diseases served as a reference group (Table 1) .
BIOCHEMICAL ASSAYS
Three 24-hour urine samples (of which the highest concentrations are given) for the determination of norepinephrine and epinephrine were obtained before surgery, and one 24-hour urine collection was obtained at 1 and at 3 months after surgery. Blood samples for the determination of normetanephrine, metanephrine, norepinephrine, and epinephrine in plasma were drawn into 10-mL heparinized tubes through an intravenous cannula in the forearm. Patients rested in the supine position for 20 minutes before blood sampling. Additional blood samples were subsequently collected after 10 minutes in the upright position in all patients. Blood pressure and heart rate were measured repeatedly. None of the patients was taking acetaminophen, which can interfere with the plasma normetanephrine assay. 6 Intraoperatively, blood was obtained at baseline (after intubation, before skin incision) and during maximal mechanical tumor manipulation in 15 patients. Blood samples were also drawn from a central venous cannula immediately before and repeatedly after clipping of the adrenal vein to follow the time course of plasma metanephrine and catecholamine levels in 6 patients. All blood samples were transferred into prechilled heparinized tubes, immediately placed on ice, and centrifuged (4°C, 2000 rpm) within 15 minutes to separate the plasma. Plasma was stored at −80°C before assay. The study was approved by the appropriate institutional review boards, and all patients gave their informed consent to participate.
The high-performance liquid chromatography method for the determination of plasma metanephrines 6 was optimized by modifications in the extraction and chromatographic procedures. Briefly, extraction was performed on solid-phase extraction columns (Isolute SCX; International Sorbent Technology, Hengoed, South Wales), and an electrochemical detector with microdialysis cells (Colouchem II; ESA, Chelmsford, Mass) was used for chromatography. This allowed detection of plasma concentrations of normetanephrine as low as 55 pmol/L and of metanephrine as low as 82 pmol/L. Recovery was estimated to range from 90% to 105% of the internal standard. The interassay coefficients of variation were 5% (normetanephrine) and 8% (metanephrine) at physiologic plasma hormone concentrations ±1 SD (normetanephrine, 430 ± 30 pmol/L; metanephrine, 150 ± 10 pmol/L). Upper limits of the normal range were adapted from Lenders et al 5 to allow comparison of results (normetanephrine, 660 pmol/L; metanephrine, 300 pmol/L; norepinephrine, 3000 pmol/L; and epinephrine, 540 pmol/L).
Plasma catecholamines were analyzed by reversephase high-performance liquid chromatography 9 with the use of plasma catecholamine extraction tubes (ESA) for the isolation procedure. Interassay and intra-assay coefficients of variance were less than 5% for both compounds.
Urine samples were collected in plastic flasks containing 10 mL of 25% hydrochloric acid. After extraction by ionexchange columns and separation by high-performance liquid chromatography, catecholamines were measured by electrochemical detection (Pharmacia KB, Uppsala, Sweden) by means of kits (Chromsystem, Munich, Germany).
DATA ANALYSIS
The 3 tests involved the determination of 2 compounds (plasma normetanephrine and metanephrine, plasma norepinephrine and epinephrine, and urinary norepinephrine and epinephrine). A positive or negative result was defined as normal or elevated values, respectively, for both substances in the pair. Preoperative values were obtained before the institution of ␣-blockade in 16 patients. Two patients (1 with life-threatening paroxysms of hypertension and 1 with sustained hypertension Ͼ250/140 mm Hg) had been taking this medication for 3 and 10 days before the first blood sample was drawn. Diagnostic procedures were evaluated by sensitivity, specificity, and positive and negative predictive values. 10 
STATISTICAL ANALYSIS
Comparisons of sensitivity or specificity between plasma metanephrines and other biochemical tests were performed with the use of the McNemar test.
11 Median increases of plasma metanephrine and catecholamine concentrations during the upright position test and the maximum intraoperative stress, respectively, were analyzed by the Wilcoxon rank sum test. The differences in the extent of increase above the upper reference limit of normal among the biochemical tests (both preoperatively and during surgery) were compared by analysis of variance with Scheffé post hoc test. The correlation between tumor mass and biochemical test results was described by the Spearman rank correlation.
nephrine with or without metanephrine was positive in all patients with pheochromocytoma. In contrast, plasma norepinephrine level was normal in 4 patients with pheochromocytoma (2 with sporadic and 2 with familial adrenal tumors). Plasma epinephrine level was normal in 9 of 17 patients with pheochromocytoma (2 with familial adrenal tumors, 6 with sporadic adrenal tumors, and 1 with a sporadic extra-adrenal tumor). Three of these patients had elevated plasma norepinephrine concentrations. Both plasma norepinephrine and epinephrine levels were therefore normal in 3 of 17 patients with pheochromocytoma ( Figure 1 ). Similarly, urinary norepinephrine concentration was normal in 5 patients with pheochromocytoma (3 with sporadic and 2 with familial adrenal tumors). One of these patients (with sporadic adrenal disease) had elevated urinary epinephrine concentration. Seven patients with pheochromocytoma (1 with a familial tumor, 5 with sporadic adrenal tumors, and 1 with a sporadic extraadrenal tumor) had urinary epinephrine concentrations within the normal range. Four of them, however, had elevated urinary norepinephrine excretion. Overall, urinary norepinephrine and epinephrine levels were within the normal range in 3 of 17 patients with pheochromocytoma ( Figure 1) .
The sensitivity of plasma metanephrines (normetanephrine and metanephrine) for the diagnosis of pheochromocytoma was 100% and thus 17% higher than that of plasma (82%; PϽ.001) and urinary (82%; PϽ.001) norepinephrine and epinephrine concentrations ( Table 2 ).
In patients with pheochromocytoma, plasma normetanephrine concentrations were increased up to approximately 1000% above the upper reference limit (Figure 1) , which was not larger (P =.77) than the increase in plasma norepinephrine level but considerably higher (PϽ.001) than that in plasma metanephrine (600%) and epinephrine (400%) concentrations, and in the urinary excretion of norepinephrine (600%) and epinephrine (550%).
POSTURE DEPENDENCE
Mean plasma norepinephrine concentration increased (P=.03) in all patients with pheochromocytoma by 300% in response to change to the upright position (Figure 2) . The median increase was 19858 pmol/L (range, 1478-35460 pmol/L), whereas plasma normetanephrine concentrations did not change significantly. Plasma epineph- rine displayed a trend (P = .07) to rise (median increase, 546 pmol/L; range, 27-8190 pmol/L) in 14 patients. Four patients (who had adrenal pheochromocytoma with normal plasma epinephrine levels) had identical or lower plasma epinephrine concentrations in the upright compared with the supine position. Plasma metanephrine concentrations were not significantly different. Similarly, plasma norepinephrine level was increased (P=.02) in the upright posture, while plasma concentrations of epinephrine (P=.09), normetanephrine, and metanephrine were not significantly higher in patients with other adrenal tumors (Figure 2 ).
INTRAOPERATIVE STRESS DEPENDENCE
Plasma norepinephrine concentrations rose (P = .002) markedly during surgery (Figure 3 ) in all patients with pheochromocytoma (median increase, 164 000 pmol/L; range, 6800-2240 000 pmol/L) when measured during maximal mechanical tumor manipulation and compared with that before skin incision. Plasma normetanephrine level did not change significantly (median increase, 7370 pmol/L; range, 300-22600 pmol/L). Plasma epinephrine level increased (P=.009) markedly in all patients (median increase, 24 730 pmol/L; range, 440-371280 pmol/L), while plasma metanephrine level did not. Again, the extent of increase above the upper reference limit of normal in response to intraoperative mechanical stress was higher (PϽ.001) for plasma catecholamines than for plasma metanephrines. Similar results were obtained in patients with other adrenal tumors (Figure 3 ).
The size of the tumor in patients with pheochromocytoma but not in those with other adrenal tumors correlated positively with the preoperative plasma concentrations of normetanephrine (r =0.70; PϽ.001) and metanephrine (r=0.62; PϽ.001) but not with plasma norepinephrine (r = 0.18; P = .86) or epinephrine (r = 0.28; P=.68).
INTRAOPERATIVE TIME COURSE OF PLASMA METANEPHRINES AND CATECHOLAMINES
Plasma concentrations of catecholamines and metanephrines were studied in 6 patients during unilateral laparoscopic adrenal surgery for sporadic (n=5) and familial (n=1) pheochromocytoma (Figure 4) . A transient increase in catecholamine level and, to a lesser extent, in metanephrine level was seen after clipping of the adrenal vein and before a fall in the respective plasma concentrations. Another patient with the familial disease had increased plasma metanephrine level (498 pmol/L), borderline plasma normetanephrine level (628 pmol/L), and elevated urinary epinephrine excretion (41 µg/24 h). This patient remained asymptomatic and refused further diagnostic and therapeutic procedures.
POSTOPERATIVE EVALUATION
COMMENT
Plasma concentrations of unconjugated normetanephrine and metanephrine showed superior sensitivity (PϽ.01) for the diagnosis of pheochromocytoma compared with plasma and urinary catecholamines. While plasma and urinary catecholamines were increased in only 83% of patients, plasma metanephrines were elevated in all patients. This is in keeping with previous findings in sporadic pheochromocytoma 6 and, more recently, MEN 2 and von Hippel-Lindau disease. 5 In particular, all patients with pheochromocytoma in our study could be identified by determination of plasma normetanephrine alone. Thus, one patient with a small pheochromocytoma and normal plasma normetanephrine concentrations described by Eisenhofer et al 7 continues to represent the only false-negative normetanephrine result reported so far in histologically confirmed pheochromocytoma.
The present study also found that plasma metanephrine concentrations are largely unsusceptible to external influences such as change of posture (Figure 2) or the mechanical stress imposed by either endoscopic or open surgery (Figure 3 ). In contrast, large increases in plasma catecholamine levels were observed in response to these procedures, findings that were observed equally in patients with pheochromocytoma and those with histologically documented other adrenal tumors. This is in keeping with results obtained by others in humans (by means of glucagon stimulation or insulin hypoglycemia tests) that show plasma metanephrine levels to be insensitive to short-term increase of plasma catecholamine levels. 8 This independence of external influences indicates that determination of plasma metanephrine levels will not require time-consuming standardization of blood sampling necessary for correct determination of plasma catecholamine levels and will be therefore more suitable as a screening test.
Tumor volume was highly correlated with plasma metanephrine concentrations but not with plasma catecholamine levels, supporting evidence that metaneph- 
